Proteomic identification of novel proteins in cortical lewy bodies
- PMID: 17388944
- PMCID: PMC8095629
- DOI: 10.1111/j.1750-3639.2007.00048.x
Proteomic identification of novel proteins in cortical lewy bodies
Abstract
Lewy body (LB) inclusions are one of the pathological hallmarks of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). One way to better understand the process leading to LB formation and associated pathogenesis responsible for neurodegeneration in PD and DLB is to examine the content of LB inclusions. Here, we performed a proteomic investigation of cortical LBs, obtained by laser capture microdissection from neurons in the temporal cortex of dementia patients with cortical LB disease. Analysis of over 2500 cortical LBs discovered 296 proteins; of those, 17 had been associated previously with brainstem and/or cortical LBs. We validated several proteins with immunohistochemical staining followed by confocal microscopy. The results demonstrated that heat shock cognate 71 kDa protein (also known as HSC70, HSP73, or HSPA10) was indeed not only colocalized with the majority of LBs in the temporal cortex but also colocalized to LBs in the frontal cortex of patients with diffuse LB disease. Our investigation represents the first extensive proteomic investigation of cortical LBs, and it is expected that characterization of the proteins in the cortical LBs may reveal novel mechanisms by which LB forms and pathways leading to neurodegeneration in DLB and/or advanced PD. Further investigation of these novel candidates is also necessary to ensure that the potential proteins in cortical LBs are not identified incorrectly because of incomplete current human protein database.
Figures


Similar articles
-
Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.Am J Pathol. 2002 May;160(5):1655-67. doi: 10.1016/S0002-9440(10)61113-3. Am J Pathol. 2002. PMID: 12000718 Free PMC article.
-
Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.Brain Res. 1999 Oct 2;843(1-2):53-61. doi: 10.1016/s0006-8993(99)01848-x. Brain Res. 1999. PMID: 10528110
-
LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies.Acta Neuropathol. 2021 Jul;142(1):117-137. doi: 10.1007/s00401-021-02313-3. Epub 2021 Apr 28. Acta Neuropathol. 2021. PMID: 33913039 Free PMC article.
-
Formation and development of Lewy pathology: a critical update.J Neurol. 2009 Aug;256 Suppl 3:270-9. doi: 10.1007/s00415-009-5243-y. J Neurol. 2009. PMID: 19711116 Review.
-
An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease.Neuropathology. 2017 Apr;37(2):129-149. doi: 10.1111/neup.12348. Epub 2016 Nov 14. Neuropathology. 2017. PMID: 27862327 Review.
Cited by
-
Mutant mice with rod-specific VPS35 deletion exhibit retinal α-synuclein pathology-associated degeneration.Nat Commun. 2024 Jul 23;15(1):5970. doi: 10.1038/s41467-024-50189-0. Nat Commun. 2024. PMID: 39043666 Free PMC article.
-
Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.Parkinsons Dis. 2011 Feb 17;2011:708404. doi: 10.4061/2011/708404. Parkinsons Dis. 2011. PMID: 21403906 Free PMC article.
-
Alpha-synuclein and tau: teammates in neurodegeneration?Mol Neurodegener. 2014 Oct 29;9:43. doi: 10.1186/1750-1326-9-43. Mol Neurodegener. 2014. PMID: 25352339 Free PMC article. Review.
-
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases.Front Neurosci. 2017 May 16;11:254. doi: 10.3389/fnins.2017.00254. eCollection 2017. Front Neurosci. 2017. PMID: 28559789 Free PMC article. Review.
-
α-synuclein Induces Mitochondrial Dysfunction through Spectrin and the Actin Cytoskeleton.Neuron. 2018 Jan 3;97(1):108-124.e6. doi: 10.1016/j.neuron.2017.11.036. Epub 2017 Dec 14. Neuron. 2018. PMID: 29249285 Free PMC article.
References
-
- Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li JY, Liu Y, Waichunas D, Montine TJ, Zhang J (2006) Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis 9:293–348. - PubMed
-
- Adam GC, Sorensen EJ, Cravatt BF (2002) Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype. Nat Biotechnol 20:805–809. - PubMed
-
- Adams JR, Van Netten H, Schulzer M, Mak E, McKenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ (2005) PET in LRRK2 mutations: comparison to sporadic Parkinson’s disease and evidence for presymptomatic compensation. Brain 128:2777–2785. - PubMed
-
- Aebersold R, Goodlett DR (2001) Mass spectrometry in proteomics. Chem Rev 101:269–295. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous